Abstract：Objective To study the clinical effect and complications of continuous blood purification (CBP) in the treatment of multiple organ dysfunction syndrome (MODS) in neonates. Methods A retrospective analysis was performed for the clinical data of 21 neonates with MODS who were admitted to the neonatal intensive care unit from November 2015 to April 2019 and were treated with CBP. Clinical indices were observed before treatment, at 6, 12, 24, and 36 hours of CBP treatment, and at the end of treatment to evaluate the clinical effect and safety of CBP treatment. Results Among the 21 neonates with MODS undergoing CBP, 17 (81%) had response to treatment. The neonates with response to CBP treatment had a significant improvement in oxygenation index at 6 hours of treatment, a significant increase in urine volume at 24 hours of treatment, a stable blood pressure within the normal range at 24 hours of treatment, and significant reductions in the doses of the vasoactive agents epinephrine and dopamine at 6 hours of treatment (P + level at 6 hours of treatment, a significant improvement in blood pH at 12 hours of treatment, and significant reductions in blood lactic acid, blood creatinine, and blood urea nitrogen at 12 hours of treatment (P Conclusions CBP is a safe, feasible, and effective method for the treatment of MODS in neonates, with few complications.
ZHANG Wei-Feng,CHEN Dong-Mei,WU Lian-Qiang et al. Clinical effect of continuous blood purification in treatment of multiple organ dysfunction syndrome in neonates[J]. CJCP, 2020, 22(1): 31-36.
Lin JC, Spinella PC, Fitzgerald JC, et al. New or progressive multiple organ dysfunction syndrome in pediatric severe sepsis:a sepsis phenotype with higher morbidity and mortality[J]. Pediatr Crit Care Med, 2017, 18(1):8-16.
[7]
Bestati N, Leteurtre S, Duhamel A, et al. Differences in organ dysfunctions between neonates and older children:a prospective, observational, multicenter study[J]. Crit Care, 2010, 14(6):R202.
[8]
Peruzzi L, Bonaudo R, Amore A, et al. Neonatal sepsis with multi-organ failure and treated with a new dialysis device specifically designed for newborns[J]. Case Rep Nephrol Urol, 2014, 4(2):113-119.
[9]
Sanchez-de-Toledo J, Perez-Ortiz A, Gil L, et al. Early initiation of renal replacement therapy in pediatric heart surgery is associated with lower mortality[J]. Pediatr Cardiol, 2016, 37(4):623-628.
[10]
Cavagnaro Santa María F, Roque Espinosa J, Guerra Hernández P. Continuous venovenous hemofiltration in neonates with hyperammonemia. A case series[J]. Rev Chil Pediatr, 2018, 89(1):74-78.
[11]
Lai YC, Huang HP, Tsai IJ, et al. High-volume continuous venovenous hemofiltration as an effective therapy for acute management of inborn errors of metabolism in young children[J]. Blood Purif, 2007, 25(4):303-308.
Sutherland SM, Alexander SR. Continuous renal replacement therapy in children[J]. Pediatr Nephrol, 2012, 27(11):2007-2016.
[15]
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network:report of an initiative to improve outcomes in acute kidney injury[J]. Crit Care, 2007, 11(2):R31.
[16]
Pereira M, Rodrigues N, Godinho I, et al. Acute kidney injury in patients with severe sepsis or septic shock:a comparison between the ‘Risk, Injury, Failure, Loss of kidney function, End-stage kidney disease’ (RIFLE), Acute Kidney Injury Network (AKIN) and Kidney Disease:Improving Global Outcomes (KDIGO) classifications[J]. Clin Kidney J, 2017, 10(3):332-340.
